Japanese medtech firm AI Medical Service has raised 8 billion yen ($70 million) in a Series C funding round led by Masayoshi Son’s SoftBank Vision Fund 2, along with other existing investors Globis Capital Partners, World Innovation Lab, and Incubate Fund.
AIM develops an AI decision support tool for endoscopists who are screening for abnormalities, including signs of gastrointestinal cancer, in...
